In conclusion, this study demonstrated the involvement of PREP in the pathogenesis of IPF and that PREP- inhibition, mediated by KYP-2047 treatment, has a protective role in lung injury induced by BLM, suggesting PREP as a potential target therapy for IPF. The gene discussed is PREP; the disease is idiopathic pulmonary fibrosis.